-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Reimagining Outcomes in Hemophilia: Improving Efficacy and Reducing Treatment Burden with High-Sustained Factor and Non-Factor Replacement Therapies

Sponsor: Sanofi
Program: Friday Satellite Symposia
Hematology Disease Topics & Pathways:
Diseases, Therapies
Friday, December 8, 2023: 11:00 AM-2:00 PM
Pacific Ballroom Salons 18-19 (Marriott Marquis San Diego Marina)
Guy Young, MD, Children's Hospital Los Angeles
Young: Spark: Consultancy, Speakers Bureau; Genentech, Inc.: Research Funding; Genentech/Roche: Consultancy; Novo Nordisk: Consultancy; Hema Biologics: Speakers Bureau; Hema Biologics/LFB: Consultancy; Takeda: Consultancy, Research Funding; Sanofi Genzyme: Consultancy, Speakers Bureau; CSL Behring: Consultancy, Speakers Bureau; Viatris: Patents & Royalties.
Glaivy Batsuli, MD, Stanford University and Cindy A. Leissinger, MD, Tulane University School of Medicine
Leissinger: Chiesi: Other: Advisor; CSL Behring: Other: Advisor; Bayer: Other: Advisor; Dova: Other: Advisor; Genentech/Roche: Other: Advisor; GBT: Other: Advisor; Takeda: Other: Advisor; Sanofi: Other: Advisor.
On Demand program will be available here mid-January.

This session will explore the latest understanding of hemostasis as it relates to the pathology of hemophilia, highlight the mechanism of action, using clinical animations, of new and emerging hemophilia treatments, discuss the efficacy and safety of novel therapies, and utilize clinical case scenarios to explore practical implications of newly approved and upcoming therapies.